Goldman Sachs’s Westlake Chemical Partners WLKP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.85M Buy
219,658
+13,352
+6% +$287K ﹤0.01% 3723
2025
Q4
$3.92M Sell
206,306
-21,856
-10% -$422K ﹤0.01% 3966
2025
Q3
$4.79M Sell
228,162
-2,343
-1% -$51.3K ﹤0.01% 3685
2025
Q2
$5.09M Buy
230,505
+1,620
+0.7% +$36.7K ﹤0.01% 3393
2025
Q1
$5.28M Buy
228,885
+8,424
+4% +$201K ﹤0.01% 3296
2024
Q4
$5.1M Buy
220,461
+79,313
+56% +$1.82M ﹤0.01% 3436
2024
Q3
$3.16M Buy
141,148
+685
+0.5% +$15.6K ﹤0.01% 3748
2024
Q2
$3.17M Buy
140,463
+885
+0.6% +$19.7K ﹤0.01% 3564
2024
Q1
$3.1M Buy
139,578
+1,761
+1% +$39.5K ﹤0.01% 3516
2023
Q4
$2.98M Buy
137,817
+687
+0.5% +$15K ﹤0.01% 3602
2023
Q3
$2.98M Sell
137,130
-375
-0.3% -$8.38K ﹤0.01% 3436
2023
Q2
$2.98M Sell
137,505
-53,171
-28% -$1.16M ﹤0.01% 3556
2023
Q1
$4.2M Sell
190,676
-6,634
-3% -$156K ﹤0.01% 3206
2022
Q4
$4.64M Sell
197,310
-3,622
-2% -$82.1K ﹤0.01% 3244
2022
Q3
$4.32M Buy
200,932
+20,021
+11% +$483K ﹤0.01% 3254
2022
Q2
$4.51M Sell
180,911
-3,374
-2% -$90.3K ﹤0.01% 3231
2022
Q1
$4.99M Sell
184,285
-4,922
-3% -$131K ﹤0.01% 3358
2021
Q4
$5.08M Sell
189,207
-193,168
-51% -$4.79M ﹤0.01% 3392
2021
Q3
$9.31M Buy
382,375
+41,266
+12% +$1.08M ﹤0.01% 2798
2021
Q2
$9.18M Buy
341,109
+26,927
+9% +$716K ﹤0.01% 2767
2021
Q1
$7.55M Buy
314,182
+30,266
+11% +$712K ﹤0.01% 2796
2020
Q4
$6.77M Sell
283,916
-82,700
-23% -$1.68M ﹤0.01% 2774
2020
Q3
$6.87M Sell
366,616
-30,192
-8% -$599K ﹤0.01% 2647
2020
Q2
$7.51M Sell
396,808
-52,797
-12% -$961K ﹤0.01% 2473
2020
Q1
$6.64M Buy
449,605
+128,191
+40% +$2.68M ﹤0.01% 2411
2019
Q4
$8.49M Buy
321,414
+24,137
+8% +$554K ﹤0.01% 2551
2019
Q3
$6.91M Buy
297,277
+519
+0.2% +$11.8K ﹤0.01% 2614
2019
Q2
$7.3M Buy
296,758
+151,944
+105% +$3.51M ﹤0.01% 2592
2019
Q1
$3.29M Sell
144,814
-21,925
-13% -$500K ﹤0.01% 3285
2018
Q4
$4.02M Sell
166,739
-26,150
-14% -$604K ﹤0.01% 3060
2018
Q3
$4.8M Sell
192,889
-4,549
-2% -$115K ﹤0.01% 3015
2018
Q2
$4.84M Sell
197,438
-4,208
-2% -$97.8K ﹤0.01% 2987
2018
Q1
$4.51M Buy
201,646
+2,829
+1% +$66.7K ﹤0.01% 2985
2017
Q4
$4.96M Sell
198,817
-43,734
-18% -$988K ﹤0.01% 3018
2017
Q3
$5.51M Buy
242,551
+53,808
+29% +$1.3M ﹤0.01% 3050
2017
Q2
$4.67M Sell
188,743
-49,873
-21% -$1.23M ﹤0.01% 3116
2017
Q1
$6M Sell
238,616
-3,213
-1% -$77.7K ﹤0.01% 2791
2016
Q4
$5.24M Sell
241,829
-22,160
-8% -$476K ﹤0.01% 3016
2016
Q3
$6.03M Sell
263,989
-120,219
-31% -$2.73M ﹤0.01% 2890
2016
Q2
$7.68M Sell
384,208
-6,908
-2% -$138K ﹤0.01% 2525
2016
Q1
$7.71M Sell
391,116
-174,127
-31% -$3.23M ﹤0.01% 2421
2015
Q4
$12.5M Buy
565,243
+207,106
+58% +$3.75M ﹤0.01% 2081
2015
Q3
$6.27M Sell
358,137
-739,365
-67% -$15.2M ﹤0.01% 2674
2015
Q2
$23.9M Buy
1,097,502
+98,566
+10% +$2.36M 0.01% 1656
2015
Q1
$26.8M Buy
998,936
+29,508
+3% +$776K 0.01% 1550
2014
Q4
$28.1M Buy
969,428
+384,881
+66% +$11M 0.01% 1570
2014
Q3
$17M Buy
+584,547
New +$17.7M 0.01% 1926

Other funds holding WLKP

Goldman Sachs's WLKP Position: Q1 2026 in Review

Goldman Sachs increased its Westlake Chemical Partners (WLKP) stake by 6.5% in Q1 2026, buying an estimated $287K and bringing the position to 219,658 shares worth $4.85M. The position accounts for ﹤0.01% of the portfolio, ranked #3723.

Goldman Sachs first reported a position in WLKP in Q3 2014 and has held it in 47 quarters since. The position peaked at $28.1M in Q4 2014. 57 funds tracked by Wall St. Rank hold WLKP as of Q1 2026.

  • Goldman Sachs held 219,658 shares of Westlake Chemical Partners worth $4.85M as of Q1 2026.
  • Goldman Sachs bought 13,352 Westlake Chemical Partners shares in Q1 2026, an estimated $287K.
  • Westlake Chemical Partners made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3723 holding.
  • Goldman Sachs first reported a position in Westlake Chemical Partners in Q3 2014 and has held it in 47 quarters since.
  • Goldman Sachs's Westlake Chemical Partners position peaked at $28.1M in Q4 2014.
  • 57 funds tracked by Wall St. Rank held Westlake Chemical Partners as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.